Zomedica Corp. (ZOM)
USD 0.12
(-2.8%)
USD 0.12
(-2.8%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 253.19 Million USD | -9.45% |
| 2023 | 279.61 Million USD | -0.28% |
| 2022 | 280.39 Million USD | 323.92% |
| 2021 | 66.14 Million USD | 1481.26% |
| 2020 | 4.18 Million USD | -30.67% |
| 2019 | 6.03 Million USD | 15.68% |
| 2018 | 5.21 Million USD | 6.98% |
| 2017 | 4.87 Million USD | 26.3% |
| 2016 | 3.86 Million USD | 2556.05% |
| 2015 | 145.34 Thousand USD | -31.29% |
| 2014 | 211.53 Thousand USD | 117.38% |
| 2013 | 97.31 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 FY | 253.19 Million USD | -9.45% |
| 2024 Q1 | 279.59 Million USD | -0.0% |
| 2024 Q3 | 275.05 Million USD | 0.1% |
| 2024 Q4 | 253.19 Million USD | -7.95% |
| 2024 Q2 | 274.77 Million USD | -1.72% |
| 2023 Q4 | 279.61 Million USD | -0.95% |
| 2023 Q1 | 277.99 Million USD | -0.86% |
| 2023 Q3 | 282.29 Million USD | 2.48% |
| 2023 FY | 279.61 Million USD | -0.28% |
| 2023 Q2 | 275.47 Million USD | -0.9% |
| 2022 Q1 | 280.46 Million USD | 324.03% |
| 2022 Q2 | 280.35 Million USD | -0.04% |
| 2022 Q3 | 277.5 Million USD | -1.02% |
| 2022 Q4 | 280.39 Million USD | 1.04% |
| 2022 FY | 280.39 Million USD | 323.92% |
| 2021 Q3 | 56.6 Million USD | 72.78% |
| 2021 Q2 | 32.76 Million USD | 550.74% |
| 2021 Q4 | 66.14 Million USD | 16.85% |
| 2021 FY | 66.14 Million USD | 1481.26% |
| 2021 Q1 | 5.03 Million USD | 20.36% |
| 2020 Q1 | 5.89 Million USD | -2.31% |
| 2020 Q4 | 4.18 Million USD | -36.73% |
| 2020 FY | 4.18 Million USD | -30.67% |
| 2020 Q2 | 9.47 Million USD | 60.83% |
| 2020 Q3 | 6.61 Million USD | -30.26% |
| 2019 Q4 | 6.03 Million USD | 43.98% |
| 2019 Q3 | 4.19 Million USD | -34.7% |
| 2019 Q1 | 4.89 Million USD | -6.14% |
| 2019 Q2 | 6.41 Million USD | 31.1% |
| 2019 FY | 6.03 Million USD | 15.68% |
| 2018 Q2 | 4.68 Million USD | 22.97% |
| 2018 Q4 | 5.21 Million USD | -19.94% |
| 2018 Q3 | 6.51 Million USD | 39.02% |
| 2018 FY | 5.21 Million USD | 6.98% |
| 2018 Q1 | 3.81 Million USD | -21.83% |
| 2017 Q1 | 82.14 Thousand USD | -27.42% |
| 2017 FY | 4.87 Million USD | 26.3% |
| 2017 Q4 | 4.87 Million USD | -9.91% |
| 2017 Q3 | 5.41 Million USD | 124.44% |
| 2017 Q2 | 2.41 Million USD | 2835.47% |
| 2016 Q1 | 145.04 Thousand USD | -16.6% |
| 2016 FY | 3.86 Million USD | 2556.05% |
| 2016 Q4 | 113.17 Thousand USD | -4.28% |
| 2016 Q3 | 118.23 Thousand USD | -13.34% |
| 2016 Q2 | 136.42 Thousand USD | -5.94% |
| 2015 FY | 145.34 Thousand USD | -31.29% |
| 2015 Q1 | 211.53 Thousand USD | -6.7% |
| 2015 Q4 | 173.91 Thousand USD | -9.62% |
| 2015 Q2 | 206.17 Thousand USD | -2.54% |
| 2015 Q3 | 192.43 Thousand USD | -6.66% |
| 2014 Q3 | 73.46 Thousand USD | -10.58% |
| 2014 FY | 211.53 Thousand USD | 117.38% |
| 2014 Q4 | 226.72 Thousand USD | 208.63% |
| 2014 Q2 | 82.15 Thousand USD | 0.0% |
| 2013 FY | 97.31 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| China Pharma Holdings, Inc. | 16.46 Million USD | -1437.397% |
| cbdMD, Inc. | 16.19 Million USD | -1463.4% |
| cbdMD, Inc. | 16.19 Million USD | -1463.4% |